QR Code (код быстрого отклика)

High‐risk cytogenetic abnormalities in multiple myeloma: PETHEMA‐GEM experience

Abstract This study examines the impact of cytogenetic abnormalities and their co‐segregation on the prognosis of newly diagnosed multiple myeloma patients. The analysis included 1304 patients from four different GEM‐PETHEMA clinical trials. Genetic alterations, such as t(4;14), t(14;16), del(17p),...

Полное описание

Сохранить в:
Главные авторы: Veronica González‐Calle, Paula Rodriguez‐Otero, Maria J. Calasanz, Manuela Guijarro, Joaquin Martínez‐López, Laura Rosiñol, Miguel T. Hernández, Ana I. Teruel, Mercedes Gironella, Albert Oriol, Javier de laRubia, Ana P. González‐Rodríguez, Joan Bargay, Felipe deArriba, Luis Palomera, Marta‐Sonia González‐Pérez, Anna Sureda, Enrique Ocio, Juan J. Lahuerta, Joan Bladé, Jesus F. San Miguel, Maria V. Mateos, Norma C. Gutiérrez
Формат: Artigo
Язык:Inglês
Опубликовано: Wiley 2024-12-01
Серии:HemaSphere
Online-ссылка:https://doi.org/10.1002/hem3.70031
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы